The diagnosis of XLA had been established at 6 months of age following an episode of bilateral pneumonia, with subsequent genetic testing identifying a hemizygous splice site variant in the BTK gene: c.895-2del (NM_000061.3), affecting the canonical splice acceptor site of intron 10. This evidence concerns the gene BTK and Bruton-type agammaglobulinemia.